Medicament for use in connection with cartilage impairment

Details Medicament for use in connection with cartilage impairment Medicament for use in connection with cartilage impairment

A - Human Necessities

61

K

A61K 31/194 (2006.01) A61K 31/198 (2006.01) A61P 19/02 (2006.01) A61P 19/10 (2006.01) A61K 38/03 (2006.01)

Patent

CA 2629683

Use of a substance for treating medical joint conditions, e.g. arthrosis, rheumatoid arthritis and cartilage impairment. The use includes the use of alpha-ketoglutaric acid, glutamine or glutamic acid, as well as salts, amides, di- or tripeptides of the mentioned substances.

La présente invention concerne l'utilisation d'une substance pour traiter des pathologies médicales des articulations, par exemple, l'arthrose, la polyarthrite rhumatoïde et la détérioration de cartilage, et notamment l'utilisation de l'acide alpha-cétoglutarique, de la glutamine ou de l'acide glutamique, ainsi que des sels, amides, di- ou tripeptides des substances mentionnées.

Affiliated with

Also associated with

Rating

Medicament for use in connection with cartilage impairment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicament for use in connection with cartilage impairment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament for use in connection with cartilage impairment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1369994